Similar articles

• Ovulation inhibition with a combined oral contraceptive containing 20 micrograms ethinyl estradiol and 250 micrograms levonorgestrel. Serum levels of the active ingredients and FSH, LH, estradiol 17-beta and progesterone.

  Lunell NO, Carlström K, Zador G. Lunell NO, et al. Acta Obstet Gynecol Scand Suppl. 1979;88:17-21. doi: 10.3109/00016347909157224. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 294110
• Hormonal content of plasma and endometrium of women taking oral contraceptives.

  Porias H, Carranco-López A, Sojo-Aranda I, González-Martínez R, Cervantes C, Parra A, Cortés-Gallegos V. Porias H, et al. Obstet Gynecol. 1978 Dec;52(6):703-7. Obstet Gynecol. 1978. PMID: 733138
• Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.

  Forleo R, Vegna G, Pala A. Forleo R, et al. Acta Eur Fertil. 1972 Jun;3(2):159-76. Acta Eur Fertil. 1972. PMID: 4679575 English, Italian. No abstract available.
• Feedback control of pituitary gonadotropins.

  Odell WD, Swerdloff RS. Odell WD, et al. Adv Biosci. 1975;15:141-62. Adv Biosci. 1975. PMID: 51805 Review. No abstract available.
• Complications of oral contraceptive agents--a symposium. Action and efficacy of systemic contraceptive agents, and introduction of complications.

  Swerdloff RS. Swerdloff RS. West J Med. 1975 Jan;122(1):20-6. West J Med. 1975. PMID: 1089002 Free PMC article. Review. No abstract available.